Laboratory Corp. of America Holdings logo

LH

Laboratory Corp. of America Holdings

$241.77

Earnings Summary

Revenue
$3606.1Mn
Net Profits
$352.8Mn
Net Profit Margins
9.78%

Highlights

Revenue:

Laboratory Corp. of America Holdings’s revenue fell -11.24% since last year same period to $3606.1Mn in the Q3 2022. On a quarterly growth basis, Laboratory Corp. of America Holdings has generated -2.46% fall in its revenue since last 3-months.

Net Profits:

Laboratory Corp. of America Holdings’s net profit fell -39.93% since last year same period to $352.8Mn in the Q3 2022. On a quarterly growth basis, Laboratory Corp. of America Holdings has generated -1.62% fall in its net profits since last 3-months.

Net Profit Margins:

Laboratory Corp. of America Holdings’s net profit margin fell -32.32% since last year same period to 9.78% in the Q3 2022. On a quarterly growth basis, Laboratory Corp. of America Holdings has generated 0.86% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Laboratory Corp. of America Holdings post its latest quarter earnings

EPS Estimate Current Quarter
4.54
EPS Estimate Current Year
4.54

Highlights

EPS Estimate Current Quarter:

Laboratory Corp. of America Holdings’s earning per share (EPS) estimates for the current quarter stand at 4.54 - a -2.78% fall from last quarter’s estimates.

EPS Estimate Current Year:

Laboratory Corp. of America Holdings’s earning per share (EPS) estimates for the current year stand at 4.54.

Key Ratios

Key ratios of the Laboratory Corp. of America Holdings post its Q2 2022 earnings

Earning Per Share (EPS)
4.96
Return on Assets (ROA)
0.08
Return on Equity (ROE)
0.17
Dividend Per Share (DPS)
0.72

Highlights

Earning Per Share (EPS):

Laboratory Corp. of America Holdings’s earning per share (EPS) fell -19.09% since last year same period to 4.96 in the Q2 2022. This indicates that the Laboratory Corp. of America Holdings has generated -19.09% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Laboratory Corp. of America Holdings’s return on assets (ROA) stands at 0.08.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Laboratory Corp. of America Holdings’s return on equity (ROE) stands at 0.17.

Dividend Per Share (DPS):

Laboratory Corp. of America Holdings declared 0.72 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2018-05-01
2.63
2.78
5.7%
2018-07-27
2.93
2.98
1.71%
2018-10-30
2.87
2.74
-4.53%
2019-02-28
2.49
2.52
1.2%

Company Information

Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Through its unparalleled diagnostics and drug development capabilities, company provides insights and accelerates innovations to improve health and improve lives. With more than 70,000 employees, Labcorp serves clients in more than 100 countries. Labcorp reported revenue of $14 billion in FY2020.

Organisation
Laboratory Corp. of America Holdings
Headquarters
358 South Main Street, Burlington, NC, United States, 27215
Employees
75000
Industry
Health Services
CEO
Adam Schechter

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*